{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:50:15Z","timestamp":1788263415105,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Deep cutaneous fungal infections (DCFIs) can cause significant morbidity in immunocompromised patients and often fail medical and standard surgical treatments because of significant subclinical extension. Although rarely considered in this setting, Mohs micrographic surgery (MMS) offers the advantages of comprehensive margin control and tissue conservation, which may be beneficial in the treatment of DCFIs that have failed standard treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To review the benefits, limitations, and practicality of MMS in patients with DCFIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A systematic review of PubMed and EMBASE was conducted to identify all cases of fungal skin lesions treated with MMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Eight case reports were identified consisting of a total of 8 patients. A majority of patients had a predisposing comorbidity (75%), with the most common being a solid organ transplant (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 3, 37.5%). The most commonly diagnosed fungal infection was phaeohyphomycosis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 5, 62.5%), followed by mucormycosis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2, 25%). No recurrence or complication post-MMS was noted at a mean follow-up of 11.66 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Although not a first-line treatment, MMS can be considered as an effective treatment alternative for DCFIs in cases of treatment failure and can be particularly helpful in areas where tissue conservation is imperative.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000002761","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:13:54Z","timestamp":1600157634000},"page":"94-97","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Beyond Skin Tumors: A Systematic Review of Mohs Micrographic Surgery in the Treatment of Deep Cutaneous Fungal Infections"],"prefix":"10.1097","volume":"47","author":[{"given":"Hanieh","family":"Zargham","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofianne","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cerrene N.","family":"Giordano","sequence":"additional","affiliation":[{"name":"Penn Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold William","family":"Higgins","sequence":"additional","affiliation":[{"name":"Penn Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.clindermatol.2011.09.006","article-title":"Classification of subcutaneous and systemic mycoses","volume":"30","author":"Arenas","year":"2012","journal-title":"Clin Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2002.1278","article-title":"Systemic mycoses in the immunocompromised host: an update in antifungal therapy","volume":"53","author":"Kontoyiannis","year":"2003","journal-title":"J Hosp Infect"},{"issue":"Suppl 3","key":"R3-20250731","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.ijid.2009.11.024","article-title":"Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors","volume":"14","author":"Ambrosioni","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1085-5629(97)80043-0","article-title":"Fungal infections in HIV-infected patients","volume":"16","author":"Durden","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11908-009-0063-x","article-title":"New immunosuppressive agents and risk for invasive fungal infections","volume":"11","author":"Maschmeyer","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"R7-20250731","first-page":"417","article-title":"Opportunistic deep cutaneous mycoses in solid organ transplant recipients","volume":"149","author":"Tessari","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3410\/M3-14","article-title":"Emerging fungal infections in immunocompromised patients","volume":"3","author":"Low","year":"2011","journal-title":"F1000 Med Rep"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0190-9622(89)70124-9","article-title":"Opportunistic fungal infections in immunocompromised hosts","volume":"20","author":"Radentz","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00128071-200304080-00003","article-title":"Therapeutic approaches to subcutaneous mycoses","volume":"4","author":"Koga","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1590\/abd1806-4841.20132018","article-title":"Treatment of superficial mycoses: review. Part II","volume":"88","author":"Dias","year":"2013","journal-title":"An Bras Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(05)70335-1","article-title":"Phaeohyphomycosis","volume":"14","author":"Rinaldi","year":"1996","journal-title":"Dermatol Clin"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/00006534-199606000-00011","article-title":"Soft-tissue fungal infections: surgical management of 12 immunocompromised patients","volume":"97","author":"Heinz","year":"1996","journal-title":"Plast Reconstr Surg"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/16.1.1","article-title":"Treatment of opportunistic fungal infections","volume":"16","author":"Armstrong","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/clinids\/19.1.67","article-title":"Mucormycosis: emerging prominence of cutaneous infections","volume":"19","author":"Adam","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archsurg.1979.01370310073013","article-title":"Mycotic wound infections. A new challenge of the surgeon","volume":"114","author":"Codish","year":"1979","journal-title":"Arch Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0022-3468(87)80206-3","article-title":"Invasive aspergillosis in children","volume":"22","author":"Golladay","year":"1987","journal-title":"J Pediatr Surg"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/clinids\/15.1.17","article-title":"Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review","volume":"15","author":"Benedict","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11908-013-0387-4","article-title":"Endemic mycoses in immunocompromised hosts","volume":"15","author":"Malcolm","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1097-0142(195705\/06)10:3<644::AID-CNCR2820100336>3.0.CO;2-Z","article-title":"Mohs FE: chemosurgery in cancer, gangrene and infections","volume":"10","author":"Breed","year":"1957","journal-title":"Cancer"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"146","DOI":"10.12788\/j.sder.0112","article-title":"Subcutaneous (deep) fungal infections","volume":"33","author":"Elgart","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"R23-20250731","first-page":"195","article-title":"Opportunistic invasive fungal infections: diagnosis & clinical management","volume":"139","author":"Badiee","year":"2014","journal-title":"Indian J Med Res"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1524-4725.1986.tb02085.x","article-title":"Chromoblastomycosis treated by Mohs micrographic surgery","volume":"12","author":"Pavlidakey","year":"1986","journal-title":"J Dermatol Surg Oncol"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/DSS.0000000000000625","article-title":"Refractory cutaneous alternariosis successfully treated with Mohs surgery and full-thickness skin grafting","volume":"42","author":"Simpson","year":"2016","journal-title":"Dermatol Surg"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/dsu.12225","article-title":"Phaeohyphomycosis of the hand treated using Mohs micrographic surgery","volume":"39","author":"Tran","year":"2013","journal-title":"Dermatol Surg"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jaad.2012.08.027","article-title":"Mohs micrographic surgery for the treatment of localized cutaneous alternariosis","volume":"68","author":"Kleker","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R28-20250731","first-page":"231","article-title":"Mohs micrographic surgery for the eradication of phaeohyphomycosis of the hand","volume":"30","author":"Bogle","year":"2004","journal-title":"Dermatol Surg"},{"key":"R29-20250731","first-page":"882","article-title":"Mohs micrographic surgery as an alternative treatment method for cutaneous mucormycosis","volume":"29","author":"Clark","year":"2003","journal-title":"Dermatol Surg"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1524-4725.1999.08184.x","article-title":"Mohs micrographic surgery for fungal soft tissue infections","volume":"25","author":"Sachse","year":"1999","journal-title":"Dermatol Surg"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"AB159","DOI":"10.1016\/j.jaad.2016.02.628","article-title":"Management of subcutaneous phaeohyphomycosis via Mohs micrographic surgery","volume":"74","author":"Yakish","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archfaci.2011.563","article-title":"Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies","volume":"13","author":"Seth","year":"2011","journal-title":"Arch Facial Plast Surg"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous mucormycosis","volume":"92","author":"Castrej\u00f3n-P\u00e9rez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/JCM.44.3.892-898.2006","article-title":"Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans","volume":"44","author":"Liang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R36-20250731","first-page":"58","article-title":"Myocutaneous mucormycosis in a diabetic burnt patient led to upper extremity amputation; A case report","volume":"5","author":"Ayaz","year":"2017","journal-title":"Bull Emerg Trauma"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinids\/10.3.551","article-title":"Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis","volume":"10","author":"Ferguson","year":"1988","journal-title":"Rev Infect Dis"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaad.2009.08.046","article-title":"Safety of peak serum lidocaine concentration after Mohs micrographic surgery: a prospective cohort study","volume":"63","author":"Alam","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjd.14843","article-title":"Safety, complications and patients' acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group","volume":"176","author":"Hussain","year":"2017","journal-title":"Br J Dermatol"},{"key":"R41-20250731","first-page":"777","article-title":"Monitoring vital signs during outpatient Mohs and post-Mohs reconstructive surgery performed under local anesthesia","volume":"30","author":"Larson","year":"2004","journal-title":"Dermatol Surg"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2011.08.010","article-title":"Needs assessment for Mohs micrographic surgery","volume":"30","author":"Asgari","year":"2012","journal-title":"Dermatol Clin"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/43.2.267","article-title":"Risk factors for amphotericin B-induced nephrotoxicity","volume":"43","author":"Luber","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1358\/dot.2003.39.10.799473","article-title":"Clinical impact of drug-drug interactions with systemic azole antifungals","volume":"39","author":"Bates","year":"2003","journal-title":"Drugs Today (Barc)"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.det.2011.01.008","article-title":"Current procedural terminology coding for Mohs micrographic surgery","volume":"29","author":"Knudson","year":"2011","journal-title":"Dermatol Clin"},{"key":"R48-20250731","first-page":"310","article-title":"Coding for biopsies, shave removals, and excisions","volume":"96","author":"Alam","year":"2015","journal-title":"Cutis"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:37Z","timestamp":1753999957000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002761","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]}}}